Institute of Organic Chemistry, Karlsruhe Institute of Technology (KIT) , Fritz-Haber-Weg 6, D-76131 Karlsruhe, Germany.
Division 2-Informatics, Economics and Society, Karlsruhe Institute of Technology (KIT) , Kaiserstraße 12, D-76131 Karlsruhe, Germany.
Chem Rev. 2016 Jul 27;116(14):8193-255. doi: 10.1021/acs.chemrev.6b00010. Epub 2016 Jul 13.
Glycosaminoglycans (GAGs) as one major part of the glycocalyx are involved in many essential biological cell processes, as well as in many courses of diseases. Because of the potential therapeutic application of GAG polymers, fragments, and also derivatives toward different diseases (e.g., heparin derivatives against Alzheimer's disease), there is a continual growing demand for new chemical syntheses, which suffice the high claim to stereoselectivity and chemoselectivity. This Review summarizes the progress of chemical syntheses of GAGs over the last 10 years. For each class of the glycosaminoglycans-hyaluronan (HA), heparan sulfate/heparin (HS/HP), chondroitin/dermatan sulfate (CS/DS), and keratan sulfate (KS)-mainly novel glycosylation strategies, elongation sequences, and protecting group patterns are discussed, but also (semi)automated syntheses, enzymatic approaches, and functionalizations of synthesized or isolated GAGs are considered.
糖胺聚糖 (GAGs) 作为糖萼的主要组成部分之一,参与许多重要的生物细胞过程,以及许多疾病的进程。由于 GAG 聚合物、片段甚至衍生物在治疗不同疾病方面(例如肝素衍生物治疗阿尔茨海默病)具有潜在的应用,因此对满足高立体选择性和化学选择性要求的新化学合成方法的需求不断增长。本文综述了过去 10 年 GAG 化学合成的进展。对于糖胺聚糖的每一类——透明质酸 (HA)、硫酸乙酰肝素/肝素 (HS/HP)、软骨素/硫酸皮肤素 (CS/DS) 和硫酸角质素 (KS)——主要讨论了新颖的糖基化策略、延伸序列和保护基模式,同时还考虑了 (半)自动化合成、酶法方法以及合成或分离的 GAG 的功能化。